Cryoport (CYRX) revenue breakdown
By segment, Life Sciences Services is the largest at 57% of fiscal 2025 revenue, growing 12% a year over 2 years.
By product, Product is the largest at 45% of fiscal 2025 revenue; BioStorage/BioServices grew fastest, 26% a year over 3 years.
Revenue by segment
Fiscal years, as Cryoport reports them in its 10-K filings; fiscal 2025 total $176M.
| Segments | 2019 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|
| Life Sciences Services | — | — | $81M | $85M | $101M | 57% |
| Life Sciences Products | — | $102M | $87M | $71M | $75M | 43% |
| Life Science Supply Chain Solutions | — | $135M | — | — | — | — |
| Global Logistics Solutions | $31M | — | — | — | — | — |
| Global Bioservices | $3M | — | — | — | — | — |
Revenue by product
Fiscal years, as Cryoport reports them in its 10-K filings; fiscal 2025 total $176M.
| Products | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Product | — | — | — | — | — | $103M | $89M | $75M | $80M | 45% |
| BioLogistics Solutions | — | — | — | — | — | $125M | $66M | $67M | $78M | 44% |
| BioStorage/BioServices | — | — | — | — | — | $9M | $14M | $15M | $18M | 10% |
| Biopharmaceutical | — | — | — | — | $180M | — | — | — | — | — |
| Service | — | — | — | $55M | — | — | — | — | — | — |
| Animal Health | — | — | — | — | $33M | — | — | — | — | — |
| Biopharma/Pharma | — | — | $30M | — | — | — | — | — | — | — |
| Product | — | — | — | $23M | — | — | — | — | — | — |
| Biopharma/Pharma | $9M | $16M | — | — | — | — | — | — | — | — |
| Reproductive Medicine | — | — | — | — | $9M | — | — | — | — | — |
| Reproductive Medicine | — | — | $3M | — | — | — | — | — | — | — |
| Reproductive Medicine | $2M | $2M | — | — | — | — | — | — | — | — |
| Animal Health | — | — | $996,000 | — | — | — | — | — | — | — |
| Animal Health | $1M | $976,000 | — | — | — | — | — | — | — | — |
Revenue by region
Fiscal years, as Cryoport reports them in its 10-K filings; fiscal 2025 total $176M.
| Regions | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $11M | $18M | $29M | $50M | $120M | $128M | $118M | $114M | $131M | 75% |
| EMEA | $963,000 | $1M | $5M | $20M | $59M | $67M | $28M | $27M | $25M | 14% |
| Asia Pacific | $353,000 | $384,000 | $618,000 | $9M | $43M | $42M | $23M | $16M | $20M | 11% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for CYRX.
Open CYRX in InvestinglyQuestions
Where does Cryoport make its money?
In fiscal 2025, by segment: Life Sciences Services $101M, Life Sciences Products $75M.
From Cryoport's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.